AusCann Group Holdings (ASX:AC8) obtained a AU$1 million loan from Endpoints Capital as an advance tax refund for its research and development activities, according to a Friday filing with the Australian bourse.
The advance incurs an interest rate of 16% per annum, with a minimum period of 90 days. The loan is expected to be repaid once the tax refund is received or by Nov. 30, whichever is earlier.
The advance is part of the cannabis drug developer's expected research and development tax incentive of AU$1.965 million for financial year 2024.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.